N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide
C58H45F3N8O9S4 — CID 88920006
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide
N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide (PubChem CID 88920006) has the molecular formula C58H45F3N8O9S4 and a molecular weight of 1183.31 g/mol. Its IUPAC name is N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide.
Molecular Properties
| Compound Name | N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide |
|---|---|
| PubChem CID | 88920006 |
| Molecular Formula | C58H45F3N8O9S4 |
| Molecular Weight | 1183.31 g/mol |
| Exact Mass | 1182.21 |
| IUPAC Name | N-[[4-[3-(difluoromethoxy)phenyl]sulfonylphenyl]methyl]imidazo[1,2-a]pyrimidine-6-carboxamide;N-[[4-(3-fluoro-5-methylphenyl)sulfonylphenyl]methyl]-N-[[4-(1-methylindazol-4-yl)sulfonylphenyl]methyl]-1,3-benzothiazole-6-carboxamide |
| SMILES | Cc1cc(F)cc(S(=O)(=O)c2ccc(CN(Cc3ccc(S(=O)(=O)c4cccc5c4cnn5C)cc3)C(=O)c3ccc4ncsc4c3)cc2)c1.O=C(NCc1ccc(S(=O)(=O)c2cccc(OC(F)F)c2)cc1)c1cnc2nccn2c1 |
| InChI | InChI=1S/C37H29FN4O5S3.C21H16F2N4O4S/c1-24-16-28(38)19-31(17-24)49(44,45)29-11-6-25(7-12-29)21-42(37(43)27-10-15-33-35(18-27)48-23-39-33)22-26-8-13-30(14-9-26)50(46,47)36-5-3-4-34-32(36)20-40-41(34)2;22-20(23)31-16-2-1-3-18(10-16)32(29,30)17-6-4-14(5-7-17)11-25-19(28)15-12-26-21-24-8-9-27(21)13-15/h3-20,23H,21-22H2,1-2H3;1-10,12-13,20H,11H2,(H,25,28) |
| InChIKey | KFIXCQAXHULCBV-UHFFFAOYSA-N |
| XLogP | 10.23 |
| TPSA | 221.96 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 82 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1183.31 |
| LogP ≤ 5 | 10.23 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88920006 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.